The efficacy of botox in treating peyronie disease; a clinnical trial
Not Applicable
- Conditions
- peyronie disease.induratio penis plastica
- Registration Number
- IRCT201203129274N1
- Lead Sponsor
- Research Deputy of Ahvaz University of Medical Science and Health science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 10
Inclusion Criteria
Inclusion criterion: stable peyronie plaque. Exclusion criteria : active phase of peyronie disease; less than 1 year history of peyronie disease and allegy to botox
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of plaque. Timepoint: preinjection and postinjection(8,16 weeks later ). Method of measurement: with sonography , milimeter.;Penile curvature. Timepoint: preinjection and postinjection(8,16 weeks later ). Method of measurement: with photography , degree.;Imprvement of sexual intercourse. Timepoint: preinjection and postinjection(8,16 weeks later ). Method of measurement: clinical.
- Secondary Outcome Measures
Name Time Method Side effect. Timepoint: preinjection and post injection (8 ,16 weeks later ). Method of measurement: clinical.